Statement re: Foot & Mouth

Genus PLC
12 September 2007


For Immediate Release                                         12 September 2007


                                   Genus Plc

                           ('Genus' or 'the Company')


                    Statement regarding Foot & Mouth Disease

Genus, the leading global multi species genetics company makes the following
statement in relation to the instance of foot and mouth disease that has been
reported today.


In line with the Company's announcement on 6 August 2007 Genus confirms the
instance of foot and mouth disease will have no measurable impact upon its
business.

The comparatively harsh foot and mouth outbreak in 2001 had no adverse impact on
the business. Since then, Genus has developed both geographically and in
species. Currently, only 14% of company turnover is in GB animal related
business.

All of Genus' GB breeding stock facilities are located far from the source of
the outbreak. Nevertheless, we have further enhanced our already high
bio-security procedures.

The Board will keep the situation under constant review and will make a further
announcement if the situation changes from that described above.

For further information, please contact:

Genus Plc Tel: [phone]
Richard Wood, Chief Executive

Buchanan Communications Tel: [phone]
Charles Ryland / Suzanne Brocks

Notes to Editors:


Genus is a world leader in applying science to animal breeding. The unique
combination of quantitative genetics and biotechnology used by Genus is
applicable across all livestock species and enables farmers and producers to
produce higher quality and healthier non-GMO food products. Genus' current
products and services enable producers and farmers to enhance milk and meat
quality and improve efficiency through the application of genetic selection.


Genus' business units, ABS (dairy and beef cattle) and PIC (pigs) sell breeding
animals and semen to customers who produce offspring which yield greater
production efficiency, milk and meat quality for the global dairy and meat
supply chain. Genus' competitive differentiation lies in its ownership and
control of its proprietary lines of breeding animals, its biotechnology used to
improve them and its global production and distribution network.


Genus' technology and products add value throughout the global supply chain of
farmers, breeders, processors, distributors, retailers and consumers.


Headquartered in Basingstoke, England, Genus companies operate in 30 countries
on five continents, with laboratories located in Madison, USA.




                      This information is provided by RNS
            The company news service from the London Stock Exchange